108 childrenThe trial included 108 children with sickle cell anemia aged 5–12 years with severe malnutrition.
Nigeriadrépanocytose · malnutritionpublished 2025Nutrition research (New York, N.Y.)PubMeddocument of 6 observations
Gold tier: mechanically validated evidence, with its primary source.
682 evidence items · page 21 / 28
108 childrenThe trial included 108 children with sickle cell anemia aged 5–12 years with severe malnutrition.
Nigeriadrépanocytose · malnutritionpublished 2025Nutrition research (New York, N.Y.)PubMeddocument of 6 observations
0.17 Cohen's_dWomen with sickle cell disease had lower utility scores with a small effect size (d = 0.17).
Nigeriadrépanocytosepublished 2019PloS onePubMeddocument of 5 observations
0.9 %CYP2C19 *2/*2 genotype frequency was 0.9% in the SCD group.
Nigeriadrépanocytosepublished 2010Journal of clinical pharmacy and therapeuticseurope_pmcdocument of 10 observations
16.7 %The overall hearing loss prevalence was 16.7% in sickle cell disease patients.
Nigeriadrépanocytosepublished 2025Nigerian journal of clinical practicePubMeddocument of 5 observations
75 %Most of the antibodies (75%) belonged to the Rh blood group system.
Nigeriadrépanocytosepublished 2021ImmunohematologyPubMeddocument of 7 observations
100 %For HbSS phenotype, isoelectric focusing showed 100% specificity, sensitivity, positive predictive value (PPV), and negative predictive value (NPV).
Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 23 observations
18.18 metabolic_ratioTwo non-SCD volunteers with metabolic ratios of 18.18 and 25.76 and one SCD patient with a metabolic ratio of 16.77 were classified as poor metabolizers of proguanil.
Nigeriadrépanocytosepublished 2016Pharmacology research & perspectiveseurope_pmcdocument of 5 observations
46.4 %The mutant genotypes MTR 2756 AG/GG were recorded in 46.4% of subjects with disease severity score >7.
Nigeriadrépanocytosepublished 2022West African journal of medicinePubMeddocument of 5 observations
0 %The overall prevalence of primary hypothyroidism among children with sickle cell anaemia in this study was 0%.
Nigeriadrépanocytose · primary hypothyroidismpublished 2023Ethiopian journal of health sciencesPubMeddocument of 7 observations
11.5 %Among 26 alloimmunized sickle cell disease participants, Lewis alloantibodies were observed in 11.5%.
Nigeriadrépanocytosepublished 2025Transfusion and apheresis science : official journal of the World Apheresis Association : europe_pmcdocument of 9 observations
Ventricular dysfunction was more prevalent in the crisis than in the steady state.
Nigeriadrépanocytosepublished 2020Cardiology in the youngPubMeddocument of 6 observations
9.8 %Headaches occurred in 9.8% of the 133 children with sickle cell disease.
Nigeriadrépanocytose · headacheobserved March 2022 and February 2025PubMeddocument of 8 observations
15.4 %15.4% of the participants had good knowledge of SCD.
Nigeriadrépanocytosepublished 2020The Pan African medical journalPubMeddocument of 8 observations
1.3 %1.3% of moderate-to-severe anaemia among children aged 6–59 months in Nigeria was attributable to sickle cell disease.
Nigeriaanémie · drépanocytoseobserved 2018published 2022BMJ openeurope_pmcdocument of 6 observationsDOI 10.1136/bmjopen-2022-063369
12.8 %Seizures were the most frequent neurological manifestation, occurring in 12.8% of the 133 children with sickle cell disease.
Nigeriadrépanocytose · seizuresobserved March 2022 and February 2025PubMeddocument of 8 observations
27.8 %Among 205 patients with sickle cell disease, 57 (27.8%) had never had a transfusion.
Nigeriadrépanocytosepublished 2025Transfusion and apheresis science : official journal of the World Apheresis Association : europe_pmcdocument of 9 observations
3 malesThree males and two females with sickle cell disease were described among the patients with acute leukaemia.
Nigeriadrépanocytose · leukaemiapublished 2020African health sciencesPubMeddocument of 3 observations
12 folliclesWomen with HbSS had significantly lower median AFC of 12.0 compared to the HbAA group with median AFC of 15.0.
Nigeriadrépanocytosepublished 2026Scientific reportsPubMeddocument of 7 observations
-0.616 correlation_coefficientGlomerular filtration rate was negatively correlated with irreversible percentage sickle cell count (r = -0.616, P = 0.0001).
Nigeriadrépanocytosepublished 2024The Nigerian postgraduate medical journalPubMeddocument of 10 observations
9.4 %The 17 death cases contributed 9.4% (95% CI 5.9 to 14.5) of all sickle cell disease admissions.
Nigeriadrépanocytoseobserved 2012 to 2021published 2024PloS onePubMeddocument of 12 observations
55.6 %Left ventricular hypertrophy was observed in 10 out of 45 (55.6%) pediatric sickle cell anaemia patients with vaso-occlusive crises.
Nigeriadrépanocytoseobserved 2023published 2025BMC pediatricsPubMeddocument of 16 observations
503 patientsThe study recruited 503 SCD patients aged ≥15 years from five Nigerian sites.
Nigeriadrépanocytosepublished 2025Gates open researchPubMeddocument of 5 observations
-0.366 correlation_coefficientHopelessness had a modest negative correlation with hemoglobin concentration (r = -0.366, P < 0.001) among clinically stable Nigerian adults with sickle cell disease.
Nigeriadrépanocytosepublished 2020Nigerian journal of clinical practicePubMeddocument of 8 observations
8.06 severity_scoreThe mean SCA severity score was 8.06 ± 3.64, signifying a moderate SCA severity in the study population.
Nigeriadrépanocytoseobserved between September 2018 and March 2019published 2021African health sciencesPubMeddocument of 3 observations
73.2 %30 (73.2%) of the healthcare workers have recommended Newborn Screening for Sickle Cell Disease to caregivers.
Nigeriadrépanocytosepublished 2024Frontiers in public healtheurope_pmcdocument of 8 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.